Clinical trial
Measurement of Potential Biomarkers Predicting Erlotinib Response
NCT01123460 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Measurement of Potential Biomarkers Predicting Erlotinib Response
- Lead sponsor
- ECOG-ACRIN Cancer Research Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 12, 2010
- Completion date
- June 12, 2010
- Enrollment
- 127 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer